Professor Richard Scolyer’s Final Days After Cancer Recurrence - Colitco
Professor Richard Scolyer’s brain cancer has returned. Despite groundbreaking treatment, he now faces a poor prognosis and cherishes time with family.
colitco.comHere are the latest publicly reported updates I can share:
- Reports in March 2026 indicated that Professor Richard Scolyer’s brain tumor had progressed, with imaging suggesting increased tumor burden and impact on brain function. This was covered by multiple outlets and noted as a difficult section of his illness, though his team continued to provide care and his advocacy remained ongoing.[1][7]
- Subsequent coverage in March 2026 highlighted ongoing treatment discussions and updates on his condition, including his involvement with public-facing health updates and charitable efforts such as the Tour de Cure event in Australia. The tone across outlets emphasized resilience and continued participation in advocacy despite progression.[2][8]
- Earlier 2025 reporting reflected positive milestones in his treatment history, including immunotherapy research and hopes tied to glioblastoma management, but those pieces predate the 2026 progression news. They underscored his prominence in melanoma and cancer research and his role as Australian of the Year in 2024.[2]
If you’d like, I can pull key excerpts from these articles, summarize the timeline of updates, or set up a quick alert, so you get notified as new information becomes available.